Biodesix Inc
Micro Cap · Healthcare · Diagnostics & Research
$23.67−$0.33 (-1.38%)
Biodesix Inc
Micro Cap · Healthcare · Diagnostics & Research
$23.67−$0.33 (-1.38%)
Stock analysis
Get the AI take on BDSX
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$5.26
High$24.92
Today $23.67
RSI (14)
67.3Neutral
03070100
Overall score
N/A/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Current price
$23.67
Lowest
$27
Median target
$33.5
Highest
$40
LowHigh
Operating Record
Revenue
What's working
- Price / sales: You're paying a modest amount for each dollar of revenue coming in.
- Current ratio: What's on hand comfortably covers the bills due over the next year.
What to watch
- Debt exceeds cash by $41.8M, increasing balance-sheet pressure, a warning sign.
- ROIC: Capital plowed back into the business isn't earning much for its trouble.
What the market charges
Forward P/E
No signal · Not enough data to judge
-
Price / sales
Strong · Priced modestly against the revenue it brings in
2.46x
Price / FCF
No signal · Not enough data to judge
-
EV / EBITDA
No signal · Not enough data to judge
-
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
-16.7%
ROE
Weak · Weak returns on shareholders' money
-540.0%
Debt / equity
Rich · Carrying more debt than equity can comfortably absorb
7.85x
Current ratio
Strong · Comfortable room to cover bills due within a year
2.85x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $253.23M | - | +34.5% | - |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |